🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials in this register

19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Second-line Standard Treatment Sequential TAS-102 and Bevacizumab Combined With Local Treatment in Advanced Colorectal Cancer
NCT06856187Metastatic Colorectal Cancer (CRC)
Fudan University
Phase 2
119
Shanghai
2025-02-28
Not yet open
Real-World Study of Myopia Prevention and Control in Children
NCT06849895Myopia, Refractive Errors, Children, Cohort
Shanghai Eye Disease Prevention and Treatment Center
Observational
15,000
Shanghai
2025-02-28
Not yet open
Familial Breast Cancer in China
NCT06833216Breast Carcinoma, Genetic Variation
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
500
Beijing
2025-02-28
Recruiting
JY231 Injection for the Treatment of Relapsed/Refractory Neurologic Immune Disorders
NCT06797024Autoimmune Diseases of the Nervous System
Tongji Hospital
Not applicable
20
Wuhan
2025-02-28
Recruiting
A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer
NCT06764316Hepatocellular Carcinoma
Bayer
Phase 1
148
Xuhui
2025-02-28
Active, closed
A Phase 2 in Adult Subjects With Hereditary Angioedema
NCT06846398Hereditary Angioedema (HAE)
Shanghai Argo Biopharmaceutical Co., Ltd.
Phase 2
25
Beijing, Lanzhou, Wuhan, Yantai, Chengdu, Kunming
2025-02-28
Recruiting
LDRT Combined With Immunochemotherapy for Colorectal Cancer With Liver Metastasis
NCT06848465Colorectal Cancer, Liver Metastasis, LDRT
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase 1
9
Chongqing
2025-02-28
Recruiting
BC001 in Combination with Sintilimab and XELOX in the Treatment of HER-2 Negative Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma.
NCT06773312Advanced or Metastatic Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.
Phase 1
80
Beijing
2025-02-28
Not yet open
Effect of Food-derived Active Components on Digestive Tract Health in Adults with Irritable Bowel Syndrome
NCT06779214Irritable Bowel Syndrome - Diarrhoea
Peking University
Not applicable
180
Beijing
2025-02-28
Recruiting
Second-line Immunotherapy for ES-SCLC
NCT06853678Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Tianjin Medical University Cancer Institute and Hospital
Not applicable
30
Tianjin
2025-02-28
Not yet open
AK135 in Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN)
NCT06860789Chemotherapy-induced Peripheral Neuropathy (CIPN)
Akeso
Phase 1
85
Guangzhou, Shanghai
2025-02-28
Recruiting
Efficacy and Safety of Weifuchun Tablet in Reversing Gastric Intestinal Metaplasia
NCT06610266Gastric Intestinal Metaplasia
Yongquan Shi
Phase 4
400
Ankang, Tongchuan, Weinan, Xi'an, Xuchang, Yanan
2025-02-28
Recruiting
An Exploratory Study to Confirm Efficacy of Modified Deep Cervical Lymphovenous Anastomosis (LVA) in Alzheimer's Disease/ Parkinson's Disease
NCT06852352Alzheimer Disease, Parkinson Disease
Zhejiang Provincial People's Hospital
Not applicable
160
Hangzhou
2025-02-28
Not yet open
Irinotecan Liposome(II) Combined With Ivonescimab as Second-line Treatment for Small Cell Lung Cancer : A Prospective, Single-arm, Multicenter Clinical Study
NCT06820762SCLC
The Second Affiliated Hospital of Dalian Medical University
Phase 2
40
Dalian, Shenyang
2025-02-28
Not yet open
Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.
NCT06485232Neuromyelitis Optica Spectrum Disorders, Myasthenia Gravis, Generalized, Multiple Sclerosis, Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Xuanwu Hospital, Beijing
Phase EARLY_PHASE1
25
Beijing
2025-02-28
By invitation
Coronary Arterial Microcirculation and Metabolism
NCT07074847Coronary Atherosclerosis of Native Coronary Artery
Shaanxi Provincial People's Hospital
Observational
100
Xi'an
2025-02-28
Not yet open
The Effects of Glasses-Free 3D Training on Visual and Cognitive Function in Presbyopic Individuals
NCT06853691Presbyopia
Zhongshan Ophthalmic Center, Sun Yat-sen University
Not applicable
60
Guangzhou
2025-02-27
Recruiting
A Study of Lianxiaxiaopi Granules in the Treatment of Postprandial Distress Syndrome
NCT06696261Postprandial Distress Syndrome
Tasly Pharmaceutical Group Co., Ltd
Phase 3
342
Beijing, Lanzhou, Guiyang, Shijiazhuang, Xingtai, Baoding, Luoyang, Changchun
2025-02-27
Recruiting
The Fifth INTEnsive pReventing Secondary Injury in Acute Cerebral Haemorrhage Trial Within ACT-GLOBAL
NCT06763055Intracerebral Hemorrhage, Spontaneous Intracerebral Hemorrhage, Supratentorial Intracerebral Haemorrhage, Acute Intracerebral Haemorrhage
The George Institute
Phase 3
2,000
Chengdu
2025-02-27
Recruiting
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
NCT06780137Small Cell Lung Cancer
Merck Sharp & Dohme LLC
Phase 1/2
327
Beijing, Fuzhou, Nanjing, Shanghai, Chengdu, Hangzhou
2025-02-27
Recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
NCT06767514Non-Small Cell Lung Cancer
Summit Therapeutics
Phase 3
780
Fuyang, Beijing, Fuzhou, Guangzhou, Nanning, Guiyang, Haikou, Harbin
2025-02-27
Active, closed
Clinical Exploration Study of YOLT-203 in the Treatment of Type 1 Primary Hyperoxaluria (PH1)
NCT06892301Type 1 Primary Hyperoxaluria
Guangzhou Women and Children's Medical Center
Phase EARLY_PHASE1
2
Guangzhou
2025-02-27
Recruiting
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
NCT06780670Prostate Cancer
Novartis Pharmaceuticals
Phase 2/3
443
Fuzhou, Wuhan, Nanjing, Shenyang, Xian, Chengdu, Beijing, Guangzhou
2025-02-27
Recruiting
Noninvasive Intratumor Heterogeneity Evaluation in HNSCC
NCT07027280Head and Neck Cancer
First Affiliated Hospital of Chongqing Medical University
Observational
700
Chongqing
2025-02-27
Recruiting
The Safety, Tolerability, and Pharmacokinetics of of SYH9017 in Chinese Participants With Overweight and Obesity
NCT06830343Overweight or Obesity
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
Phase 1
66
Beijing
2025-02-27
Recruiting
A Study to Evaluate the Safety, Tolerability, PK and PD of AP303 in DKD Patients
NCT06666283Diabetic Kidney Disease
Alebund Pharmaceuticals
Phase 1
18
Beijing
2025-02-27
Recruiting
Glofitamab Combination With Chidamide in Patients With Recurrent/Refractory DLBCL
NCT06570447Diffuse Large B-Cell Lymphoma-Recurrent, Diffuse Large B-Cell Lymphoma-Refractory
Tianjin Medical University Cancer Institute and Hospital
Phase 2
22
Tianjin
2025-02-27
Recruiting
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
NCT06722235Immune Thrombocytopenic Purpura (ITP)
Takeda
Phase 3
171
Beijing, Guangzhou, Nanning, Shijiazhuang, Wuhan, Zhengzhou, Suzhou, Nanchang
2025-02-27
Recruiting
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
NCT06731478Gastric Cancer, Gastroesophageal Junction Cancer
Daiichi Sankyo
Phase 3
726
Beijing, Changzhou, Fuzhou, Hangzhou, Harbin, Hefei, Jinan, Lanzhou
2025-02-27
By invitation
TPO Combined With TPORA for Solid Tumors Effectiveness of cTit Above Degree II
NCT06769685CTIT-Chemotherapy Induced Thrombocytopenia
Jinhua Central Hospital
Observational
100
Jinhua
2025-02-27
Recruiting
Transcutaneous Auricular Vagus Nerve Stimulation as Adjuvant Treatment for Sepsis Patients
NCT07051694Sepsis
Third Military Medical University
Not applicable
60
Chongqing
2025-02-27
Recruiting
Real-world Effectiveness and Safety of Trastuzumab Deruxtecan in Patients With Locally Advanced or Metastatic HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma in China
NCT06846996HER2-positive Gastric Cancer, HER2-positive Gastroesophageal Junction
Daiichi Sankyo
Observational
260
Beijing, Changchun, Changzhi, Fuzhou, Guangzhou, Haikou, Hangzhou, Hefei
2025-02-27
Recruiting
Effect of Reduced Vasopressors on Mortality in ECMO-supported Cardiogenic Shock Patients
NCT06862700Cardiogenic Shock, Extracorporeal Membrane Oxygenation, Vasopressors, Hemodynamic Management
Xiaotong Hou
Observational
534
Beijing
2025-02-26
Recruiting
A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors
NCT06792552Advanced Solid Tumors, Platinum Resistant Ovarian Cancer, Fallopian Tube Cancer, Renal Cell Carcinoma (RCC)
NextCure, Inc.
Phase 1
738
Beijing, Shenyang, Shijiazhuang, Guangzhou, Changsha, Jinan, Jining, Shanghai
2025-02-26
By invitation
Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of YD0293 in Healthy Subjects
NCT07098091Healthy Participants
Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
Phase 1
78
Suzhou
2025-02-26
Recruiting
Pathogen Detection in Infectious Uveitis
NCT04521673Infectious Panuveitis, Infectious Iridocyclitis
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Observational
100
Shanghai
2025-02-26
Recruiting
Evolution of Intracardiac Electrograms Recorded by Left Bundle Branch Pacing Lead in Patients With ICD or CRT-D
NCT06745778Ventricular Tachycardia (VT), Ventricular Fibrillation
Medtronic Cardiac Rhythm and Heart Failure
Observational
50
Wenzhou, Shanghai
2025-02-26
Recruiting
Effect of Aerobic Exercise With Synchronous Music on Functions Among Medical Students
NCT06788106Psychological Stress, Aerobic Exercise, Medical Students
Universiti Sains Malaysia
Not applicable
134
Yancheng
2025-02-26
Recruiting
SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors
NCT06873659Solid Tumor, Gastric Cancer, Liver Cancer
Qurgen Inc.
Phase 1
96
Beijing, Lanzhou, Guangzhou, Nanjing, Xi'an, Jinan, Shanghai, Hangzhou
2025-02-26
Recruiting
Comparative Study on the Safety and Efficacy of Using AccuSafe Transseptal Guidewire Versus Traditional Transseptal Needle for Transseptal Puncture in non-or Free- Guidance
NCT07515040Atrial Fibrillation (AF)
Second Affiliated Hospital of Nanchang University
Not applicable
80
Nanchang
2025-02-26
Recruiting
A Study of HS-20110 in Participants With Advanced Solid Tumors
NCT06892379Solid Tumors
Hansoh BioMedical R&D Company
Phase 1
475
Guangzhou
2025-02-26
Active, closed
A Phase 2, Open-label, Randomized, Multicenter Study of Tarlatamab Dosing Regimens in Subjects With SCLC
NCT06745323Small Cell Lung Cancer (SCLC)
Amgen
Phase 2
252
Beijing, Fuzhou, Guangzhou, Harbin, Changsha, Taiyuan, Chengdu, Tianjin
2025-02-26
Recruiting
Phase III Clinical Study of MG-K10 Humanized Mab Injection in Subjects With Prurigo Nodularis
NCT06779136Prurigo Nodularis
Shanghai Mabgeek Biotech.Co.Ltd
Phase 3
160
Beijing
2025-02-26
Recruiting
A Clinical Study of SHR-A1811 in the Treatment of HER2-positive Locally Advanced or Metastatic Biliary Tract Cancer
NCT06778031HER2-positive Locally Advanced or Metastatic Biliary Tract Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 2
54
Harbin, Shanghai
2025-02-26
Recruiting
UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia
NCT06245746Acute Myeloid Leukemia, Neutropenia, Anemia, Thrombocytopenia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 1
9
Wuhan
2025-02-26
Recruiting
Irinotecan Liposomes Combined with Cetuximab + Vermofenib in First-line Failure of Advanced Colorectal Cancer
NCT06763029Colorectal Cancer Metastatic
Fudan University
Phase 2
36
Shanghai
2025-02-26
Recruiting
To Evaluate the Safety and Efficacy of a Single-Use IVUS Ablation for Primary Hypertension
NCT07051811Essential Hypertension
Lepu Medical Technology (Beijing) Co., Ltd.
Not applicable
213
Beijing, Chongqing, Xiamen, Lanzhou, Shenzhen, Zhengzhou, Hohhot, Yinchuan
2025-02-25
Recruiting
Exploring the Potential Benefits of Probiotic Yogurt
NCT06847919Chronic Constipation
Wecare Probiotics Co., Ltd.
Not applicable
84
Suzhou
2025-02-25
Recruiting
Prediction of Response to PD-L1 Inhibitor After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer Using Multi-omics-based Liquid Biopsy
NCT06869239Limited-stage Small Cell Lung Cancer (LS-SCLC)
Peking University Cancer Hospital & Institute
Observational
65
Beijing
2025-02-25
Recruiting
Gestational Lifestyle & Outcomes Wellness
NCT07263412GDM
The First Affiliated Hospital with Nanjing Medical University
Observational
1,000
Nanjing
2025-02-25
Recruiting
A Study on Application of Adjustable Headrest in Painless Curettage Surgery for Overweight and Obese Patients
NCT06929000Adjustable Headrests, Ventilation Function, Obese Patients
Maternal and Child Health Hospital of Hubei Province
Not applicable
300
Wuhan
2025-02-25
Recruiting
Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells Injection in Patients With Decompensated Hepatitis B Cirrhosis
NCT07413549Decompensated Hepatitis B Cirrhosis
Beijing Tuohua Weiye Biotechnology Co., Ltd.
Phase 1/2
76
Wuhan
2025-02-25
Recruiting
mNEED: a Multicentre, Cluster-randomized, Controlled Trial
NCT06827275Feeding, ICU
The First Hospital of Jilin University
Not applicable
2,250
Changchun
2025-02-25
Recruiting
Tislelizumab Combined With Chemotherapy and Relayed Radiotherapy in First-line Treatment of ES-SCLC
NCT06838208Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Anhui Provincial Cancer Hospital
Phase 2
56
Hefei
2025-02-25
Recruiting
Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPC
NCT06811844Nasopharyngeal Neoplasms, PD-1 Inhibitor, Induction Therapy, Complete Response
The First Affiliated Hospital of Xiamen University
Phase 2
208
Xiamen, Zhangzhou, Haikou
2025-02-25
Recruiting
Brain Function and Psychological Changes Related to Cell Therapy for Autoimmune Hemolytic Anemia
NCT06921980CAR T-cell Therapy, Autoimmune Hemolytic Anemia, Brain Function, Psychological Well-Being
Institute of Hematology & Blood Diseases Hospital, China
Observational
20
Tianjin
2025-02-25
Recruiting
A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
NCT06646276Extensive-Stage Small Cell Lung Cancer
Bristol-Myers Squibb
Phase 3
530
Beijing, Chongqing, Fuzhou, Xiamen, Shantou, Harbin, Wuhan, Changsha
2025-02-25
Recruiting
Exploring the Correlation Between MRI Image Characteristics and Diagnosis, Pathology and Prognosis in Patients With Prostate Lesions
NCT06946771Prostate Carcinoma, MRI, Diagnosis
Zhen Li
Observational
500
Wuhan
2025-02-25
Recruiting
Systemic Application of Cadonilimab, LM-302, and S-1 Combined With Intraperitoneal Infusion of Paclitaxel for the Treatment of Claudin 18.2-positive Gastric Cancer With Peritoneal Metastasis
NCT06519591Gastric Cancer Stage IV, Peritoneal Metastases
Ruijin Hospital
Phase 2
40
Shanghai
2025-02-25
Recruiting
IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS)
NCT06849986Soft Tissue Sarcomas, Angiosarcoma, Fibrosarcoma, Leiomyosarcoma
Fudan University
Phase 2
45
Shanghai
2025-02-25
Active, closed
Hepatocellular Carcinoma 3 Gene Methylation Combination Detection Kit (PCR Fluorescent Probe Method) Multicenter Clinical Trial
NCT06842563Hepatocellular Carcinoma (HCC)
Singlera Genomics Inc.
Observational
900
Shanghai
2025-02-25
Recruiting
Immunonutrition Reduces Acute Esophagitis After Thoracic Radiotherapy in Lung Cancer
NCT06840704Non Small Cell Lung Cancer, Small Cell Lung Cancer
Hunan Cancer Hospital
Phase 3
121
Changsha, Chenzhou, Hengyang, Yueyang
2025-02-25
Recruiting
A Phase Ib/II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Patients With Advanced/Metastatic Solid Tumors
NCT06848699Solid Tumor Cancer, Non Small Cell Lung Cancer
Shanghai Henlius Biotech
Phase 1/2
105
Hunan, Jinan, Chongqing
2025-02-25
Not yet open
A Multicenter, Open Phase IIb Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Colorectal Cancer
NCT06838546Advanced Colorectal Cancer
Tasly Biopharmaceuticals Co., Ltd.
Phase 2
80
Hanzhou
2025-02-24
Recruiting
Phase I Study of OriC902 in Treatment of Advanced HCC
NCT06891742HCC
Peking University
Phase 1
44
Beijing
2025-02-24
Recruiting
An Exploratory Study to Evaluate the Efficacy and Safety of FCN-159 in Patients With Brain Arteriovenous Malformations
NCT06913725Brain Arteriovenous Malformations
Xuanwu Hospital, Beijing
Phase 2
10
Beijing
2025-02-24
Not yet open
Effects of Exercise Snacks and Sprint Interval Training in Overweight Adults
NCT06849453Cardiovascular Function, Cardiorespiratory Fitness
Beijing Sport University
Not applicable
45
Beijing
2025-02-24
Recruiting
A Study to Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal or Acral Melanoma Who Had Not Previously Received Systemic Therapy
NCT06797297Melanoma
Innovent Biologics (Suzhou) Co. Ltd.
Phase 2
180
Hefei, Beijing, Chongqing, Fuzhou, Guangzhou, Nanning, Shijiazhuang, Harbin
2025-02-24
Active, closed
Randomized Masked Trial of Injectable Cross-Linked Hyaluronic Acid for Moderate-to-Severe Nasolabial Folds
NCT07367204Nasolabial Fold Wrinkles
Chongqing Jinsaixing Medical Technology Co., Ltd
Not applicable
356
Beijing
2025-02-24
Recruiting
Safety and Efficacy of PA9159 Inhalation Aerosol for the Treatment of Adult Bronchial Asthma
NCT07326995Bronchial Asthma
Anhui Palo Alto Pharmaceuticals, Inc.
Phase 2
60
Nanchang
2025-02-24
Not yet open
Standardized Antihypertensive Treatment Protocol
NCT06790927Hypertension
Shanghai Jiao Tong University School of Medicine
Not applicable
400
Shanghai
2025-02-24
Recruiting
Inhaled mRNA Tumor-associated Antigen Dry Powder Vaccine in Advanced Lung Cancer and Lung Metastasis of Solid Tumors.
NCT06928922Advanced Lung Cancer, Lung Metastasis
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase EARLY_PHASE1
83
Beijing
2025-02-24
Recruiting
AI-Assisted Medical Decision-Making
NCT06846229Real-world Study
The Eye Hospital of Wenzhou Medical University
Observational
50,000,000
Wenzhou
2025-02-24
Not yet open
The Effect of General Anesthesia with Remimazolam and Propofol on Rhythmic State and Cognitive Function
NCT06775366Cognitive Functioning, Propofol, Remimazolam, Circadian Rhythm
The Second Affiliated Hospital of Chongqing Medical University
Not applicable
174
Chongqing
2025-02-24
Recruiting
Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic Alopecia
NCT07080931Androgenetic Alopecia
Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.
Phase 3
294
Beijing
2025-02-24
Recruiting
A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors
NCT06741644Advanced Solid Tumors
CStone Pharmaceuticals
Phase 1/2
800
Beijing, Changchun, Changsha, Chengdu, Fuzhou, Guangzhou, Hangzhou, Harbin
2025-02-24
Recruiting
Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacokinetics, and Preliminary Efficacy of FS-8002
NCT06832982Advanced Solid Tumors
Shanghai Pushi Medical Science Co. Ltd
Phase 1
66
Beijing, Fujian, Zhejiang, Heilongjiang, Shandong, Guangdong, Shenyang, Hebei
2025-02-24
Recruiting
A Study on the Treatment of CTIT of the Efficacy and Safety With Romiplostim N01 Compared to Recombinant Human Interleukin-11
NCT06759636CTIT: Cancer Therapy Induced Thrombocytopenia
The First Affiliated Hospital with Nanjing Medical University
Phase 3
88
Nanjing
2025-02-24
Not yet open
Efficacy and Safety of Pulsed Field Ablation in Refractory Mitral Isthmus-dependent Atrial Flutter: Pulsed Field Ablation Vs. Radiofrequency Ablation: a Preliminary Randomized Controlled Study
NCT06850064Atrial Fibrillation (AF)
Shanghai Chest Hospital
Not applicable
60
Shanghai
2025-02-24
Recruiting
A Study of BL-B01D1 in Combination With Osimertinib Versus Osimertinib as First-Line Treatment in Patients With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer(PANKU-Lung04)
NCT06838273Non-small Cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3
720
Shanghai
2025-02-24
Recruiting
Effects of Vitamin D and Prebiotic Supplementation on Glucose Control During Pregnancy
NCT06553729Glucose Intolerance During Pregnancy
Huazhong University of Science and Technology
Not applicable
500
Zhanjiang, Wuhan
2025-02-24
Recruiting
Metabolomic and Lipidomic Analysis Predicts Immunotherapy-related Adverse Events in Gastric Cancer Patients
NCT06915389Gastric Cancer, Immunotherapy, Adverse Event, Metabonomics
Qinghai Red Cross Hospital
Observational
100
Xining
2025-02-22
Not yet open
Clinical Study of NKG2D CAR-NK Combined with PD-1 Monoclonal Antibody in the Treatment of ATC
NCT06856278Anaplastic Throid Carcinoma
Zhejiang Provincial People's Hospital
Phase 1/2
30
Hangzhou
2025-02-22
Recruiting
Comparison of Ciprofol and Propofol Under IoC1 and IoC2 Monitoring for Adenotonsillectomy
NCT06882980Adenotonsillectomy, Propofol, Ciprofol
Maternal and Child Health Hospital of Hubei Province
Not applicable
236
Wuhan
2025-02-22
Recruiting
Sintilimab and Linperlisib Combination Treatment in Relapsed or Refractory Extranodal Natural Killer/T Cell Lymphoma
NCT06793956Extranodal Natural Killer/T Cell Lymphoma
Sun Yat-sen University
Phase 1
12
Guangzhou
2025-02-21
Recruiting
Clinical Effectiveness and Safety of Trastuzumab Deruxtecan (T-DXd) in Chinese Patients With HER2m NSCLC (RERUN)
NCT06809764Non-small Cell Lung Cancer
Daiichi Sankyo
Observational
150
Beijing, Changsha, Fuzhou, Guangdong, Guangzhou, Hangzhou, Hebei, Hefei
2025-02-21
Recruiting
Study of Tiprogrel in the Treatment of High-risk Patients with Acute Ischemic Cerebrovascular Events (THRIVE).
NCT06601127Ischemic Stroke
Tianjin Institute of Pharmaceutical Research Co., Ltd
Phase 2
600
Shenyang, Beijing
2025-02-21
Recruiting
CD123-CD16-NK Cells Immunotherapy for AML
NCT06835140AML (Acute Myelogenous Leukemia), NK Cell, CD123+ Acute Myeloid Leukemia
Chunji Gao
Phase 1
9
Beijing
2025-02-21
Recruiting
Evaluation of the Efficacy and Safety of Fecal Microbiota Transplantation for Constipation in Parkinson's Disease
NCT06388863Parkinson Disease
Shanghai Zhongshan Hospital
Not applicable
76
Shanghai
2025-02-21
Recruiting
Effects of Inspiratory Muscle Training on Stroke Rehabilitation Outcomes
NCT06640101Stroke
Hong Kong Metropolitan University
Not applicable
84
Shenzhen
2025-02-21
Recruiting
A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies
NCT06839105Non-Small Cell Lung Cancer, Colorectal Cancer, Renal Cell Carcinoma, Melanoma and Other Solid Tumor
Shanghai Junshi Bioscience Co., Ltd.
Phase 1
214
Fuzhou, Guangzhou, Harbin, Luoyang, Wuhan, Changsha, Nanchang, Changchun
2025-02-21
Recruiting
Evaluating Mechanically Engineered Stem Cell Exosomes for Treating Endometrial Injury: A Clinical Study
NCT06896747Thin Endometrial Lining, Female Infertility, Intrauterine Adhesions
Tang-Du Hospital
Phase 1/2
90
Xi'an
2025-02-21
Recruiting
The Cohort Construction Project of Peking University Third Hospital
NCT07761676Multiple Chronic Conditions (Unspecified), Large-scale Health Examination Cohort
Peking University Third Hospital
Observational
100,000
Beijing
2025-02-21
Active, closed
Sodium Bicarbonate for Reducing Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma.
NCT06854510Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University
Phase 2/3
196
Guangzhou
2025-02-21
Recruiting
Risk Factors for Inadequate Bowel Preparation Before Colonoscopy
NCT06878378Colonoscopy, Colonoscopy: Bowel Preparation
Changhai Hospital
Observational
10,000
Shanghai
2025-02-21
Recruiting
Phase III Trial of Camrelizumab+Apatinib+Eribulin vs. Physician's Choice Chemotherapy in Advanced Triple-Negative Breast Cancer
NCT06889688Breast Cancer Stage IV, Triple -Negative Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 3
246
Guangzhou, Guiyang, Wuhan, Yichang, Changsha, Yongzhou, Shanghai
2025-02-21
Recruiting
Organoid-guided Personalized Treatment of Pleural Effusion
NCT06959173Lung Cancer
Henan Cancer Hospital
Observational
20
Zhengzhou
2025-02-21
Active, closed
Akkermansia Probiotics Plus Anti-PD-1 Monoclonal Antibody in MSS/pMMR Advanced Colorectal Cancer
NCT06865521Colo-rectal Cancer, PD-1 Inhibitor, Akkermansia Muciniphila
West China Hospital
Not applicable
22
Chengdu
2025-02-21
Active, closed
A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis
NCT06878404Arthritis, Psoriatic
Janssen Research & Development, LLC
Phase 3
552
Beijing, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Guiyang, Linyi
2025-02-21
Recruiting
A Study on Scalp Health and Integrated Scalp Management Protocols for Hair Transplant Patients
NCT07641686Hair Transplantation, Seborrheic Dermatitis, Scalp Care
ChinaNorm
Not applicable
120
Shanghai
2025-02-21
Rows per page Showing 9301–9400 of 19052
Previous 92 93 94 95 96 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china?page=94

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

How many clinical trials are recruiting in China?

11,786 of the 19,052 studies in this register are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 3,920 have not yet opened recruitment, 2,668 are active but closed to new participants, and 678 are enrolling by invitation only. Eligibility for any study is decided by its study team.

→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.